Effect	O
of	O
cell	O
cycle	O
position	O
on	O
dexamethasone	O
binding	O
by	O
mouse	B-cell_line
and	I-cell_line
human	I-cell_line
lymphoid	I-cell_line
cell	I-cell_line
lines	I-cell_line
:	O
correlation	O
between	O
an	O
increase	O
in	O
dexamethasone	O
binding	O
during	O
S	O
phase	O
and	O
dexamethasone	O
sensitivity	O
.	O

We	O
determined	O
the	O
effect	O
of	O
cell	O
cycle	O
position	O
on	O
the	O
amount	O
of	O
dexamethasone	O
that	O
was	O
specifically	O
bound	O
by	O
mouse	B-cell_line
and	I-cell_line
human	I-cell_line
lymphoid	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Cell	B-cell_line
lines	I-cell_line
that	O
were	O
either	O
sensitive	O
or	O
resistant	O
to	O
growth	O
inhibition	O
by	O
dexamethasone	O
were	O
compared	O
.	O

Exponentially	B-cell_type
growing	I-cell_type
cells	I-cell_type
were	O
separated	O
by	O
centrifugal	O
elutriation	O
into	O
fractions	O
that	O
corresponded	O
to	O
different	O
positions	O
in	O
the	O
cell	O
cycle	O
.	O

The	O
cell	O
cycle	O
phase	O
distribution	O
of	O
each	O
fraction	O
was	O
estimated	O
by	O
flow	O
cytometry	O
and	O
autoradiography	O
.	O

The	O
amount	O
of	O
dexamethasone	O
bound	O
per	O
cell	O
in	O
each	O
fraction	O
was	O
measured	O
by	O
a	O
whole	O
cell	O
binding	O
assay	O
.	O

In	O
three	O
dexamethasone-sensitive	B-cell_line
cell	I-cell_line
lines	I-cell_line
(	O
two	O
mouse	O
and	O
one	O
human	O
)	O
,	O
we	O
found	O
that	O
the	O
amount	O
of	O
dexamethasone	O
bound	O
per	O
cell	O
increased	O
2-4-fold	O
between	O
G1	O
phase	O
and	O
S	O
phase	O
,	O
and	O
then	O
decreased	O
during	O
G2/M	O
phase	O
.	O

Results	O
were	O
the	O
same	O
when	O
the	O
amount	O
of	O
dexamethasone	O
bound	O
per	O
milligram	O
of	O
cell	B-protein
protein	I-protein
was	O
measured	O
.	O

Binding	O
affinity	O
was	O
the	O
same	O
during	O
G1	O
phase	O
and	O
S	O
phase	O
,	O
but	O
the	O
proportion	O
of	O
bound	O
dexamethasone	O
that	O
translocated	O
to	O
the	O
nucleus	O
was	O
greater	O
during	O
S	O
phase	O
.	O

In	O
contrast	O
,	O
we	O
found	O
that	O
the	O
amount	O
of	O
dexamethasone	O
bound	O
per	O
cell	O
by	O
three	O
dexamethasone-resistant	B-cell_line
cell	I-cell_line
lines	I-cell_line
(	O
two	O
mouse	O
and	O
one	O
human	O
)	O
did	O
not	O
increase	O
during	O
S	O
phase	O
.	O

Our	O
results	O
indicate	O
that	O
cell	O
cycle	O
changes	O
in	O
dexamethasone	O
binding	O
are	O
not	O
simply	O
related	O
to	O
changes	O
in	O
cell	B-protein
protein	I-protein
or	O
cell	O
volume	O
during	O
the	O
cell	O
cycle	O
.	O

An	O
increase	O
in	O
dexamethasone	O
binding	O
during	O
S	O
phase	O
may	O
be	O
required	O
for	O
dexamethasone	O
to	O
inhibit	O
cell	O
growth	O
,	O
and	O
a	O
failure	O
of	O
dexamethasone	O
binding	O
to	O
increase	O
during	O
S	O
phase	O
might	O
represent	O
a	O
new	O
mechanism	O
of	O
dexamethasone	O
resistance	O
in	O
lymphoid	B-cell_type
cells	I-cell_type
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Effect	NULL
of	NULL
Cell	NULL
Cycle	NULL
Position	NULL
on	NULL
Dexamethasone	NULL
Binding	NULL
by	NULL
Mouse	NULL
and	NULL
Human	NULL
Lymphoid	NULL
Cell	NULL
Lines	NULL
:	NULL
Correlation	NULL
Between	NULL
an	NULL
Increase	NULL
in	NULL
Dexamethasone	NULL
Binding	NULL
During	NULL
S	NULL
Phase	NULL
and	NULL
Dexamethasone	NULL
Sensitivity	NULL
Clark	NULL
W.	NULL
Distelhorst	NULL
,	NULL
Barbara	NULL
M.	NULL
Benutto	NULL
,	NULL
and	NULL
Robert	NULL
A.	NULL
Bergamini	NULL
We	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
that	NULL
was	NULL
specifically	NULL
bound	NULL
by	NULL
mouse	NULL
and	NULL
human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Cell	NULL
lines	NULL
that	NULL
were	NULL
either	NULL
sensitive	NULL
or	NULL
resistant	NULL
to	NULL
growth	NULL
inhibition	NULL
by	NULL
dexamethasone	NULL
were	NULL
compared	NULL
.	NULL

Exponentially	NULL
growing	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
into	NULL
fractions	NULL
that	NULL
corresponded	NULL
to	NULL
different	NULL
positions	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
phase	NULL
distribution	NULL
of	NULL
each	NULL
fraction	NULL
was	NULL
estimated	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
autoradiography	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
whole	NULL
cell	NULL
binding	NULL
assay	NULL
.	NULL

In	NULL
three	NULL
dexamethasone-sensitive	NULL
cell	NULL
lines	NULL
(	NULL
two	NULL
mouse	NULL
and	NULL
one	NULL
human	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
increased	NULL
2-4-fold	NULL
between	NULL
G	NULL
,	NULL
phase	NULL
and	NULL
S	NULL
phase	NULL
,	NULL
and	NULL
then	NULL
decreased	NULL
during	NULL
G	NULL
,	NULL
/M	NULL
phase	NULL
.	NULL

Results	NULL
were	NULL
the	NULL
same	NULL
when	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
HE	NULL
EFFECTS	NULL
of	NULL
glucocorticosteroids	NULL
on	NULL
cells	NULL
are	NULL
mediated	NULL
through	NULL
the	NULL
binding	NULL
of	NULL
steroid	NULL
molecules	NULL
to	NULL
specific	NULL
receptor	NULL
proteins	NULL
located	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
target	NULL
cells	NULL
.	NULL
'	NULL

Steroid-receptor	NULL
complexes	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
the	NULL
cell	NULL
,	NULL
where	NULL
they	NULL
interact	NULL
with	NULL
chromatin	NULL
to	NULL
modulate	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
many	NULL
cells	NULL
,	NULL
glucocorticoids	NULL
induce	NULL
the	NULL
synthesis	NULL
of	NULL
specific	NULL
proteins	NULL
.	NULL
``	NULL

In	NULL
lymphoid	NULL
cells	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
are	NULL
mainly	NULL
inhibitory	NULL
,	NULL
resulting	NULL
in	NULL
growth	NULL
inhibition	NULL
and	NULL
cell	NULL
death	NULL
.	NULL
``	NULL

By	NULL
studying	NULL
glucocorticoid	NULL
resistant	NULL
mutants	NULL
of	NULL
the	NULL
$	NULL
49	NULL
mouse	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
Tompkins	NULL
and	NULL
coworkers	NULL
found	NULL
that	NULL
a	NULL
variety	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
defects	NULL
were	NULL
responsible	NULL
for	NULL
the	NULL
development	NULL
of	NULL
glucocorticoid	NULL
resistance	NULL
.	NULL
``	NULL

The	NULL
defective	NULL
receptor	NULL
mutants	NULL
were	NULL
grouped	NULL
into	NULL
four	NULL
phenotypic	NULL
categories	NULL
:	NULL
receptor-activity-deficient	NULL
mutants	NULL
,	NULL
nuclear-transfer-deficient	NULL
mutants	NULL
,	NULL
nuclear-transfer-increased	NULL
mutants	NULL
,	NULL
and	NULL
the	NULL
so-called	NULL
``	NULL
death-less	NULL
``	NULL
mutants	NULL
,	NULL
which	NULL
appeared	NULL
to	NULL
be	NULL
normal	NULL
in	NULL
their	NULL
steroid	NULL
(	NULL
and	NULL
nuclear	NULL
)	NULL
binding	NULL
characteristics	NULL
.	NULL

More	NULL
recent	NULL
studies	NULL
have	NULL
been	NULL
directed	NULL
toward	NULL
understanding	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
'	NULL
and	NULL
have	NULL
uncovered	NULL
structural	NULL
defects	NULL
in	NULL
the	NULL
receptor	NULL
that	NULL
account	NULL
for	NULL
the	NULL
nuclear-transfer-increased	NULL
type	NULL
of	NULL
glucocorticoid	NULL
resistance	NULL
.	NULL

**	NULL
One	NULL
poorly	NULL
understood	NULL
property	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
involves	NULL
the	NULL
changes	NULL
that	NULL
appear	NULL
to	NULL
occur	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Recently	NULL
,	NULL
Cidlowski	NULL
and	NULL
Michaels	NULL
'	NULL
demonstrated	NULL
that	NULL
the	NULL
number	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
measured	NULL
by	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
dexamethasone	NULL
,	NULL
increased	NULL
2-3-fold	NULL
during	NULL
Blood	NULL
,	NULL
Vol	NULL
.	NULL

63	NULL
,	NULL
No	NULL
.	NULL

1	NULL
(	NULL
January	NULL
)	NULL
,	NULL
1984	NULL
:	NULL
pp	NULL
.	NULL

105-113	NULL
per	NULL
milligram	NULL
of	NULL
cell	NULL
protein	NULL
was	NULL
measured	NULL
.	NULL

Binding	NULL
affinity	NULL
was	NULL
the	NULL
same	NULL
during	NULL
G	NULL
,	NULL
phase	NULL
and	NULL
S	NULL
phase	NULL
,	NULL
but	NULL
the	NULL
proportion	NULL
of	NULL
bound	NULL
dexamethasone	NULL
that	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
was	NULL
greater	NULL
during	NULL
S	NULL
phase	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
by	NULL
three	NULL
dexamethasone-resistant	NULL
cell	NULL
lines	NULL
(	NULL
two	NULL
mouse	NULL
and	NULL
one	NULL
human	NULL
)	NULL
did	NULL
not	NULL
increase	NULL
during	NULL
S	NULL
phase	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
cell	NULL
cycle	NULL
changes	NULL
in	NULL
dexamethasone	NULL
binding	NULL
are	NULL
not	NULL
simply	NULL
related	NULL
to	NULL
changes	NULL
in	NULL
cell	NULL
protein	NULL
or	NULL
cell	NULL
volume	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

An	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
during	NULL
S	NULL
phase	NULL
may	NULL
be	NULL
required	NULL
for	NULL
dexamethasone	NULL
to	NULL
inhibit	NULL
cell	NULL
growth	NULL
,	NULL
and	NULL
a	NULL
failure	NULL
of	NULL
dexamethasone	NULL
binding	NULL
to	NULL
increase	NULL
during	NULL
S	NULL
phase	NULL
might	NULL
represent	NULL
a	NULL
new	NULL
mechanism	NULL
of	NULL
dexamethasone	NULL
resistance	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

S	NULL
phase	NULL
.	NULL

Other	NULL
investigators	NULL
showed	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
by	NULL
circulating	NULL
human	NULL
lym-phocytes	NULL
increased	NULL
after	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
mitogens	NULL
.	NULL
``	NULL

Crabtree	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
proposed	NULL
that	NULL
this	NULL
phenomenon	NULL
was	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
greater	NULL
number	NULL
of	NULL
dexamethasone	NULL
receptors	NULL
in	NULL
S	NULL
phase	NULL
cells	NULL
than	NULL
in	NULL
G	NULL
,	NULL
and	NULL
G	NULL
,	NULL
phase	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
dexamethasone	NULL
binding	NULL
by	NULL
both	NULL
dexamethasone-sensitive	NULL
and	NULL
-resistant	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Human	NULL
and	NULL
mouse	NULL
lymphoid	NULL
cell	NULL
lines	NULL
were	NULL
separated	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
into	NULL
fractions	NULL
corresponding	NULL
to	NULL
different	NULL
positions	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
simultaneously	NULL
.	NULL

The	NULL
results	NULL
show	NULL
a	NULL
correlation	NULL
between	NULL
an	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
during	NULL
S	NULL
phase	NULL
and	NULL
dexamethasone	NULL
sensitivity	NULL
.	NULL

From	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
and	NULL
Oncology	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Children	NULL
's	NULL
United	NULL
Research	NULL
Effort	NULL
.	NULL

C.	NULL
W.	NULL
D.	NULL
is	NULL
a	NULL
Special	NULL
Fellow	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

Presented	NULL
in	NULL
part	NULL
at	NULL
the	NULL
Annual	NULL
Meeting	NULL
of	NULL
the	NULL
American	NULL
Federation	NULL
for	NULL
Clinical	NULL
Research	NULL
,	NULL
May	NULL
1	NULL
,	NULL
1983	NULL
.	NULL

Submitted	NULL
May	NULL
25	NULL
,	NULL
1983	NULL
;	NULL
accepted	NULL
July	NULL
19	NULL
,	NULL
1983	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Clark	NULL
W.	NULL
Distelhorst	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
and	NULL
Oncology	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
500	NULL
South	NULL
Kingshighway	NULL
Boulevard	NULL
,	NULL
S1	NULL
.	NULL

Louis	NULL
,	NULL
MO	NULL
63110	NULL
.	NULL

©	NULL
1984	NULL
by	NULL
Grune	NULL
&	NULL
Stratton	NULL
,	NULL
Inc.	NULL
0006-497	NULL
1/84/630	NULL
1-001	NULL
3801	NULL
.00/0	NULL
105	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

106	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
[	NULL
1,2,4-	NULL
>	NULL
H	NULL
]	NULL
-Dexamethasone	NULL
(	NULL
42	NULL
Ci/mmole	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Amersham	NULL
Corp.	NULL
(	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
;	NULL
{	NULL
methyl-H	NULL
]	NULL
}	NULL
-thymidine	NULL
(	NULL
2.0	NULL
Ci/mmole	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
New	NULL
England	NULL
Nuclear	NULL
(	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Dexamethasone	NULL
,	NULL
chromomycin	NULL
A3	NULL
,	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
other	NULL
chemicals	NULL
were	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

NTB-2	NULL
nuclear	NULL
track	NULL
emulsion	NULL
and	NULL
D19	NULL
developer	NULL
were	NULL
from	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Inc.	NULL
(	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Culture	NULL
medium	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
Center	NULL
for	NULL
Basic	NULL
Cancer	NULL
Research	NULL
at	NULL
Washington	NULL
University	NULL
,	NULL
and	NULL
newborn	NULL
calf	NULL
serum	NULL
was	NULL
purchased	NULL
from	NULL
KC	NULL
Biological	NULL
,	NULL
Inc.	NULL
(	NULL
Lenexa	NULL
,	NULL
KS	NULL
)	NULL
.	NULL

Cell	NULL
Lines	NULL
The	NULL
IM-9	NULL
cell	NULL
line	NULL
was	NULL
purchased	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
8226	NULL
cell	NULL
line	NULL
was	NULL
from	NULL
Dr.	NULL
Robert	NULL
Allen	NULL
(	NULL
American	NULL
Red	NULL
Cross	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

The	NULL
$	NULL
49	NULL
W+	NULL
24.32	NULL
cell	NULL
line	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Vincent	NULL
Groppi	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
$	NULL
49	NULL
variants	NULL
and	NULL
WEHI7	NULL
M4.12	NULL
(	NULL
abbre-viated	NULL
W7	NULL
)	NULL
cell	NULL
lines	NULL
were	NULL
given	NULL
to	NULL
us	NULL
by	NULL
Dr.	NULL
Keith	NULL
Yamamoto	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cell	NULL
Cultures	NULL
$	NULL
49	NULL
and	NULL
W7	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
stationary	NULL
suspension	NULL
culture	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
DME	NULL
)	NULL
with	NULL
3	NULL
g/liter	NULL
glucose	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
newborn	NULL
calf	NULL
serum	NULL
and	NULL
were	NULL
maintained	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
10	NULL
%	NULL
CO	NULL
;	NULL
atmosphere	NULL
.	NULL

The	NULL
IM-9	NULL
and	NULL
8226	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
stationary	NULL
suspension	NULL
culture	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
glutamine	NULL
and	NULL
10	NULL
%	NULL
heat-inactivated	NULL
newborn	NULL
calf	NULL
serum	NULL
and	NULL
were	NULL
maintained	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
atmosphere	NULL
.	NULL

Centrifugal	NULL
Elutriation	NULL
Exponentially	NULL
dividing	NULL
cells	NULL
were	NULL
separated	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
cell	NULL
size	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

The	NULL
method	NULL
was	NULL
modified	NULL
after	NULL
that	NULL
of	NULL
Kaiser	NULL
et	NULL
al	NULL
.	NULL
'	NULL

''	NULL
and	NULL
has	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
cell	NULL
separation	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
Beckman	NULL
J2-21	NULL
centrifuge	NULL
equipped	NULL
with	NULL
an	NULL
elutriation	NULL
rotor	NULL
and	NULL
standard	NULL
elutriation	NULL
chamber	NULL
.	NULL

Cells	NULL
were	NULL
suspended	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
used	NULL
in	NULL
cell	NULL
culture	NULL
and	NULL
loaded	NULL
into	NULL
the	NULL
separatory	NULL
chamber	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
9	NULL
ml/min	NULL
for	NULL
$	NULL
49	NULL
and	NULL
W7	NULL
cell	NULL
lines	NULL
and	NULL
7	NULL
ml/min	NULL
for	NULL
IM-9	NULL
and	NULL
8226	NULL
cell	NULL
lines	NULL
.	NULL

Maximum	NULL
cell	NULL
load	NULL
was	NULL
4	NULL
x	NULL
10°	NULL
cells	NULL
.	NULL

Rotor	NULL
speed	NULL
was	NULL
maintained	NULL
at	NULL
2,000	NULL
rpm	NULL
for	NULL
$	NULL
49	NULL
and	NULL
W7	NULL
cell	NULL
lines	NULL
and	NULL
1,600	NULL
rpm	NULL
for	NULL
8226	NULL
and	NULL
IM-9	NULL
cell	NULL
lines	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
in	NULL
200-ml	NULL
fractions	NULL
by	NULL
stepwise	NULL
2	NULL
ml/min	NULL
increments	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
flow	NULL
of	NULL
medium	NULL
through	NULL
the	NULL
chamber	NULL
.	NULL

Cells	NULL
were	NULL
counted	NULL
with	NULL
a	NULL
hemocytometer	NULL
,	NULL
and	NULL
cell	NULL
viability	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
cells	NULL
to	NULL
exclude	NULL
trypan	NULL
blue	NULL
dye	NULL
.	NULL

Flow	NULL
Cytometry	NULL
Cells	NULL
were	NULL
fixed	NULL
with	NULL
25	NULL
%	NULL
ethanol	NULL
and	NULL
15	NULL
mM	NULL
MgCi	NULL
;	NULL
at	NULL
4°C	NULL
,	NULL
stained	NULL
with	NULL
chromomycin	NULL
A3	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
to	NULL
determine	NULL
the	NULL
population	NULL
distribution	NULL
of	NULL
DNA	NULL
content	NULL
per	NULL
cell	NULL
.	NULL
``	NULL

Flow	NULL
cytometry	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
Flow	NULL
Cytometry	NULL
Laboratory	NULL
at	NULL
Washington	NULL
University	NULL
,	NULL
using	NULL
a	NULL
Becton-Dickinson	NULL
Fluorescence	NULL
Activated	NULL
Cell	NULL
Sorter	NULL
(	NULL
FACS	NULL
IV	NULL
)	NULL
.	NULL

The	NULL
G	NULL
;	NULL
,	NULL
S	NULL
,	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
phase	NULL
content	NULL
of	NULL
each	NULL
population	NULL
was	NULL
quantified	NULL
by	NULL
the	NULL
computer	NULL
modeling	NULL
program	NULL
described	NULL
by	NULL
Dean	NULL
and	NULL
Jett	NULL
.	NULL
``	NULL

'	NULL
H-Thymidine	NULL
Incorporation	NULL
and	NULL
Autoradiography	NULL
Cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
hr	NULL
with	NULL
1.5	NULL
gCi/ml	NULL
H-thymidine	NULL
,	NULL
and	NULL
acid-precipitable	NULL
radioactivity	NULL
was	NULL
measured	NULL
by	NULL
DISTELHORST	NULL
,	NULL
BENUTTO	NULL
,	NULL
AND	NULL
BERGAMINI	NULL
previously	NULL
described	NULL
methods	NULL
.	NULL
``	NULL

Autoradiographs	NULL
of	NULL
*H-thymidine-labeled	NULL
cells	NULL
,	NULL
placed	NULL
on	NULL
microscope	NULL
slides	NULL
with	NULL
a	NULL
cytocentrifuge	NULL
,	NULL
were	NULL
prepared	NULL
exactly	NULL
as	NULL
described	NULL
by	NULL
Stein	NULL
and	NULL
Yanishevsky	NULL
,	NULL
``	NULL
``	NULL
using	NULL
NTB-2	NULL
nuclear	NULL
track	NULL
emulsion	NULL
and	NULL
an	NULL
exposure	NULL
time	NULL
of	NULL
5	NULL
days	NULL
.	NULL

At	NULL
least	NULL
600	NULL
cells	NULL
were	NULL
counted	NULL
on	NULL
each	NULL
slide	NULL
.	NULL

Cell	NULL
Volume	NULL
The	NULL
size	NULL
distribution	NULL
of	NULL
cell	NULL
populations	NULL
was	NULL
determined	NULL
in	NULL
a	NULL
model	NULL
ZBI	NULL
Coulter	NULL
counter	NULL
equipped	NULL
with	NULL
a	NULL
multichannel	NULL
analyzer	NULL
(	NULL
Channelyzer	NULL
II	NULL
,	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Dexamethasone	NULL
Binding	NULL
Dexamethasone	NULL
binding	NULL
was	NULL
measured	NULL
simultaneously	NULL
on	NULL
all	NULL
fractions	NULL
isolated	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
concentration	NULL
of	NULL
each	NULL
fraction	NULL
was	NULL
adjusted	NULL
so	NULL
that	NULL
binding	NULL
was	NULL
measured	NULL
on	NULL
an	NULL
equal	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
fraction	NULL
.	NULL

Binding	NULL
of	NULL
dexamethasone	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
whole	NULL
cell	NULL
competitive	NULL
binding	NULL
technique	NULL
,	NULL
modified	NULL
after	NULL
that	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

$	NULL
49	NULL
and	NULL
W7	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
suspended	NULL
in	NULL
DME	NULL
buffered	NULL
with	NULL
25	NULL
mM	NULL
HEPES	NULL
.	NULL

Cell	NULL
suspensions	NULL
were	NULL
transferred	NULL
to	NULL
16	NULL
x	NULL
100	NULL
mm	NULL
sterile	NULL
glass	NULL
culture	NULL
tubes	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2-5	NULL
x	NULL
10°	NULL
cells/tube	NULL
.	NULL

Cells	NULL
were	NULL
gently	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
0.6	NULL
ml	NULL
of	NULL
DME	NULL
.	NULL

To	NULL
each	NULL
0.6-ml	NULL
cell	NULL
suspension	NULL
was	NULL
added	NULL
0.4	NULL
ml	NULL
of	NULL
DME	NULL
containing	NULL
sufficient	NULL
'	NULL
H-dexamethasone	NULL
to	NULL
give	NULL
a	NULL
final	NULL
dexamethasone	NULL
concentration	NULL
of	NULL
from	NULL
2.5	NULL
nM	NULL
to	NULL
120	NULL
nM	NULL
.	NULL

Unlabeled	NULL
dexamethasone	NULL
was	NULL
added	NULL
to	NULL
an	NULL
identical	NULL
set	NULL
of	NULL
tubes	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
'	NULL
H-dexamethasone	NULL
,	NULL
so	NULL
that	NULL
the	NULL
concentration	NULL
of	NULL
dexamethasone	NULL
was	NULL
3	NULL
uM	NULL
.	NULL

In	NULL
most	NULL
experiments	NULL
,	NULL
binding	NULL
was	NULL
measured	NULL
at	NULL
a	NULL
single	NULL
concentration	NULL
of	NULL
*H-dexametha-sone	NULL
(	NULL
30	NULL
nM	NULL
,	NULL
which	NULL
is	NULL
sufficient	NULL
to	NULL
saturate	NULL
most	NULL
receptor	NULL
sites	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
3	NULL
uM	NULL
unlabeled	NULL
dexamethasone	NULL
.	NULL

The	NULL
cell	NULL
suspensions	NULL
were	NULL
covered	NULL
loosely	NULL
and	NULL
incubated	NULL
in	NULL
a	NULL
10	NULL
%	NULL
CO	NULL
,	NULL
atmosphere	NULL
at	NULL
37°C	NULL
,	NULL
with	NULL
periodic	NULL
gentle	NULL
shaking	NULL
.	NULL

Incubations	NULL
were	NULL
terminated	NULL
after	NULL
2	NULL
hr	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
3	NULL
ml	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
and	NULL
pelleting	NULL
the	NULL
cells	NULL
at	NULL
800	NULL
g	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
then	NULL
discarded	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
DME	NULL
.	NULL

The	NULL
cell	NULL
suspensions	NULL
were	NULL
incubated	NULL
at	NULL
25°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
then	NULL
the	NULL
incubation	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
3	NULL
ml	NULL
ice-cold	NULL
PBS	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pelleted	NULL
at	NULL
800	NULL
g	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
then	NULL
washed	NULL
once	NULL
again	NULL
with	NULL
3	NULL
ml	NULL
ice-cold	NULL
PBS	NULL
.	NULL

After	NULL
the	NULL
final	NULL
wash	NULL
,	NULL
cell	NULL
pellets	NULL
were	NULL
suspended	NULL
in	NULL
1	NULL
ml	NULL
ethanol	NULL
with	NULL
vigorous	NULL
vortexing	NULL
.	NULL

The	NULL
cell	NULL
suspensions	NULL
were	NULL
counted	NULL
in	NULL
3a70	NULL
;	NULL
the	NULL
counting	NULL
efficiency	NULL
was	NULL
55	NULL
%	NULL
.	NULL

Binding	NULL
at	NULL
each	NULL
concentration	NULL
of	NULL
*H-dexametha-sone	NULL
was	NULL
measured	NULL
in	NULL
triplicate	NULL
.	NULL

Specific	NULL
binding	NULL
was	NULL
defined	NULL
as	NULL
binding	NULL
of	NULL
'	NULL
H-dexamethasone	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
unlabeled	NULL
dexamethasone	NULL
minus	NULL
the	NULL
binding	NULL
of	NULL
'	NULL
H-dexamethasone	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
unlabeled	NULL
dexamethasone	NULL
.	NULL

Scatchard	NULL
plots	NULL
of	NULL
the	NULL
binding	NULL
data	NULL
were	NULL
drawn	NULL
by	NULL
linear	NULL
regression	NULL
analysis	NULL
.	NULL

Binding	NULL
of	NULL
dexamethasone	NULL
by	NULL
IM-9	NULL
and	NULL
8226	NULL
cells	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
same	NULL
method	NULL
,	NULL
except	NULL
that	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
buffered	NULL
with	NULL
25	NULL
m¥	NULL
HEPES	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
temperature	NULL
was	NULL
25°C	NULL
.	NULL

The	NULL
binding	NULL
conditions	NULL
employed	NULL
were	NULL
found	NULL
in	NULL
preliminary	NULL
studies	NULL
to	NULL
be	NULL
optimal	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
studied	NULL
.	NULL

Nuclear	NULL
and	NULL
Cytoplasmic	NULL
Fractionation	NULL
In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
amount	NULL
of	NULL
specifically	NULL
bound	NULL
dexamethasone	NULL
that	NULL
was	NULL
localized	NULL
to	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
,	NULL
cells	NULL
were	NULL
fractionated	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Berger	NULL
and	NULL
Cooper	NULL
.	NULL
``	NULL

The	NULL
binding	NULL
procedure	NULL
described	NULL
above	NULL
was	NULL
followed	NULL
,	NULL
but	NULL
after	NULL
the	NULL
final	NULL
wash	NULL
,	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
PBS	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
0.1	NULL
mi	NULL
of	NULL
cell	NULL
suspension	NULL
was	NULL
removed	NULL
for	NULL
measurement	NULL
of	NULL
whole	NULL
cell	NULL
binding	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pelleted	NULL
at	NULL
800	NULL
g	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
modified	NULL
reticulocyte	NULL
standard	NULL
buffer	NULL
{	NULL
(	NULL
modified	NULL
RSB	NULL
:	NULL
0.1	NULL
Mf	NULL
Tris-chloride	NULL
at	NULL
pH	NULL
7.4	NULL
,	NULL
0.01	NULL
¥f	NULL
NaCl	NULL
,	NULL
0.0015	NULL
M	NULL
Mg	NULL
acetate	NULL
)	NULL
and	NULL
underlayered	NULL
with	NULL
I	NULL
ml	NULL
of	NULL
RSB	NULL
containing	NULL
1	NULL
%	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EFFECT	NULL
OF	NULL
CELL	NULL
CYCLE	NULL
ON	NULL
DEXAMETHASONE	NULL
BINDING	NULL
sucrose	NULL
and	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

The	NULL
cell	NULL
suspension	NULL
was	NULL
centrifuged	NULL
at	NULL
2,200	NULL
rpm	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
then	NULL
1.5	NULL
ml	NULL
of	NULL
supernatant	NULL
was	NULL
removed	NULL
and	NULL
counted	NULL
in	NULL
3270	NULL
to	NULL
determine	NULL
cytoplasmic	NULL
binding	NULL
.	NULL

The	NULL
peliet	NULL
was	NULL
suspended	NULL
in	NULL
1	NULL
ml	NULL
ethanol	NULL
and	NULL
counted	NULL
in	NULL
3a70	NULL
to	NULL
determine	NULL
nuclear	NULL
binding	NULL
.	NULL

Nuclei	NULL
were	NULL
examined	NULL
by	NULL
phase-contrast	NULL
microscopy	NULL
and	NULL
found	NULL
to	NULL
be	NULL
intact	NULL
and	NULL
free	NULL
of	NULL
cytoplasmic	NULL
rem-nants	NULL
.	NULL

Protein	NULL
Measurement	NULL
Protein	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
method	NULL
described	NULL
by	NULL
Bradford	NULL
``	NULL
(	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
,	NULL
Bio-Rad	NULL
Laborato-ries	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
crystalline	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

RESULTS	NULL
Characterization	NULL
of	NULL
Cell	NULL
Lines	NULL
Three	NULL
clones	NULL
of	NULL
the	NULL
$	NULL
49	NULL
mouse	NULL
lymphoma	NULL
cell	NULL
line	NULL
were	NULL
studied	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

$	NULL
49	NULL
W*	NULL
24.32	NULL
is	NULL
a	NULL
``	NULL
wild	NULL
type	NULL
``	NULL
clone	NULL
,	NULL
whose	NULL
growth	NULL
is	NULL
inhibited	NULL
by	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
as	NULL
low	NULL
as	NULL
0.01	NULL
uM	NULL
.	NULL

$	NULL
49	NULL
143R	NULL
is	NULL
a	NULL
dexamethasone-resistant	NULL
mutant	NULL
that	NULL
has	NULL
an	NULL
increased	NULL
nuclear	NULL
transfer	NULL
of	NULL
dexamethasone-receptor	NULL
complexes	NULL
.	NULL

S49	NULL
22R	NULL
is	NULL
a	NULL
dexamethasone-resistant	NULL
mutant	NULL
that	NULL
has	NULL
a	NULL
decreased	NULL
nuclear	NULL
transfer	NULL
of	NULL
dexamethasone	NULL
,	NULL
receptor	NULL
complexes	NULL
.	NULL

The	NULL
whole	NULL
cell	NULL
dexamethasone	NULL
binding	NULL
capacity	NULL
of	NULL
the	NULL
sensitive	NULL
and	NULL
resistant	NULL
clones	NULL
is	NULL
similar	NULL
.	NULL

The	NULL
derivation	NULL
and	NULL
biochemical	NULL
characteristics	NULL
of	NULL
the	NULL
$	NULL
49	NULL
mutants	NULL
have	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
previously	NULL
.	NULL
``	NULL

The	NULL
M4.12	NULL
cell	NULL
line	NULL
is	NULL
a	NULL
dexamethasone-sensitive	NULL
clone	NULL
of	NULL
the	NULL
W7	NULL
mouse	NULL
thymoma	NULL
cell	NULL
line	NULL
.	NULL

Two	NULL
human	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
were	NULL
studied	NULL
,	NULL
8226	NULL
and	NULL
IM-9	NULL
.	NULL

After	NULL
screening	NULL
a	NULL
number	NULL
of	NULL
human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
for	NULL
dexamethasone	NULL
sensitivity	NULL
,	NULL
these	NULL
two	NULL
cell	NULL
lines	NULL
were	NULL
selected	NULL
for	NULL
study	NULL
because	NULL
of	NULL
a	NULL
clear	NULL
difference	NULL
in	NULL
the	NULL
effect	NULL
of	NULL
dexamethasone	NULL
on	NULL
cell	NULL
growth	NULL
.	NULL

The	NULL
growth	NULL
of	NULL
the	NULL
8226	NULL
cell	NULL
line	NULL
is	NULL
inhibited	NULL
by	NULL
dexamethasone	NULL
,	NULL
but	NULL
the	NULL
growth	NULL
of	NULL
the	NULL
IM-9	NULL
cell	NULL
line	NULL
is	NULL
107	NULL
not	NULL
inhibited	NULL
by	NULL
dexamethasone	NULL
.	NULL

The	NULL
relatively	NULL
high	NULL
dexamethasone	NULL
binding	NULL
capacity	NULL
of	NULL
the	NULL
IM-9	NULL
cell	NULL
line	NULL
and	NULL
its	NULL
resistance	NULL
to	NULL
growth	NULL
inhibition	NULL
by	NULL
dexamethasone	NULL
have	NULL
been	NULL
reported	NULL
previously	NULL
by	NULL
others	NULL
.	NULL
``	NULL

Cell	NULL
Separation	NULL
Exponentially	NULL
growing	NULL
,	NULL
unsynchronized	NULL
cells	NULL
were	NULL
reproducibly	NULL
separated	NULL
according	NULL
to	NULL
size	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

Each	NULL
fraction	NULL
was	NULL
analyzed	NULL
for	NULL
cell	NULL
size	NULL
distribution	NULL
and	NULL
for	NULL
DNA	NULL
content	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
cells	NULL
in	NULL
each	NULL
fraction	NULL
had	NULL
a	NULL
narrow	NULL
size	NULL
distribution	NULL
when	NULL
compared	NULL
to	NULL
the	NULL
original	NULL
,	NULL
asynchronous	NULL
cell	NULL
population	NULL
.	NULL

Modal	NULL
cell	NULL
volume	NULL
increased	NULL
with	NULL
each	NULL
fraction	NULL
and	NULL
approximately	NULL
doubled	NULL
between	NULL
fractions	NULL
1	NULL
and	NULL
6	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
DNA	NULL
content	NULL
per	NULL
cell	NULL
was	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Each	NULL
fraction	NULL
corresponded	NULL
to	NULL
a	NULL
different	NULL
position	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
from	NULL
G	NULL
,	NULL
phase	NULL
(	NULL
fraction	NULL
1	NULL
)	NULL
,	NULL
to	NULL
G	NULL
,	NULL
+	NULL
early	NULL
S	NULL
phase	NULL
(	NULL
fractions	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
to	NULL
mid-S	NULL
phase	NULL
(	NULL
fraction	NULL
4	NULL
)	NULL
,	NULL
to	NULL
late	NULL
S	NULL
+	NULL
G	NULL
,	NULL
phase	NULL
(	NULL
fractions	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
is	NULL
typical	NULL
of	NULL
the	NULL
type	NULL
of	NULL
separation	NULL
that	NULL
was	NULL
achieved	NULL
with	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
phase	NULL
distribution	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
estimated	NULL
by	NULL
computer	NULL
analysis	NULL
of	NULL
flow	NULL
cytometry	NULL
data	NULL
.	NULL

In	NULL
some	NULL
of	NULL
the	NULL
experiments	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
was	NULL
also	NULL
measured	NULL
by	NULL
autoradiography	NULL
of	NULL
'	NULL
H-thymidine-labeled	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
correspondence	NULL
between	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
determined	NULL
by	NULL
analysis	NULL
of	NULL
DNA	NULL
histograms	NULL
and	NULL
by	NULL
autoradiography	NULL
is	NULL
imper-fect	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
estimated	NULL
from	NULL
DNA	NULL
histograms	NULL
was	NULL
lower	NULL
than	NULL
that	NULL
determined	NULL
by	NULL
autoradiography	NULL
during	NULL
the	NULL
G	NULL
,	NULL
to	NULL
S	NULL
phase	NULL
transition	NULL
(	NULL
fractions	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

At	NULL
the	NULL
transition	NULL
from	NULL
S	NULL
to	NULL
G	NULL
,	NULL
/M	NULL
phase	NULL
(	NULL
fractions	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
Table	NULL
1	NULL
.	NULL

Dexamethasone	NULL
Sensitivity	NULL
and	NULL
Binding	NULL
by	NULL
Mouse	NULL
and	NULL
Human	NULL
Lymphoid	NULL
Cell	NULL
Lines	NULL
Cell	NULL
Count	NULL
After	NULL
Culture	NULL
With	NULL
Dexamethasone	NULL
(	NULL
Cells	NULL
x	NULL
10*/mi	NULL
)	NULL
Sgw'ﬂwllz	NULL
at	NULL
?	NULL

Amount	NULL
of	NULL
Bound	NULL
Dexamethasone	NULL
Cell	NULL
Line	NULL
0	NULL
uM	NULL
0.01	NULL
gM	NULL
0.1	NULL
uM	NULL
1	NULL
uM	NULL
(	NULL
fmole/	NULL
10°	NULL
Cells	NULL
}	NULL
Localized	NULL
to	NULL
Nucleus	NULL
(	NULL
%	NULL
)	NULL
Mouse	NULL
lymphoma	NULL
S49	NULL
w*	NULL
24.32	NULL
0.84	NULL
0.33	NULL
0.25	NULL
0.29	NULL
14.3	NULL
+	NULL
1.6	NULL
53	NULL
$	NULL
49	NULL
143R	NULL
0.94	NULL
1.28	NULL
1.00	NULL
1.13	NULL
18.0	NULL
+	NULL
4.0	NULL
74	NULL
S49	NULL
22R	NULL
0.88	NULL
1.08	NULL
1.18	NULL
1.14	NULL
10.5	NULL
+	NULL
4.0	NULL
19	NULL
Mouse	NULL
thymoma	NULL
W7	NULL
M	NULL
4.12	NULL
0.70	NULL
0.24	NULL
0.16	NULL
0.14	NULL
17.8	NULL
+	NULL
4.2	NULL
ND	NULL
Human	NULL
lymphoid	NULL
8226	NULL
0.60	NULL
ND	NULL
0.06	NULL
0.03	NULL
11.6	NULL
+	NULL
2.1	NULL
ND	NULL
IM-9	NULL
1.09	NULL
ND	NULL
1.00	NULL
1.02	NULL
69.3	NULL
+	NULL
3.8	NULL
50	NULL
To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
dexamethasone	NULL
on	NULL
cell	NULL
growth	NULL
,	NULL
mouse	NULL
lymphoma	NULL
cells	NULL
were	NULL
suspended	NULL
at	NULL
0.3	NULL
x	NULL
10°	NULL
cells/ml	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dexamethasone	NULL
or	NULL
ethanol	NULL
vehicle	NULL
and	NULL
counted	NULL
after	NULL
incubation	NULL
for	NULL
2	NULL
days	NULL
.	NULL

Human	NULL
lymphoid	NULL
cells	NULL
were	NULL
suspended	NULL
at	NULL
0.05	NULL
x	NULL
10°	NULL
cells/ml	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dexamethasone	NULL
or	NULL
ethanol	NULL
vehicle	NULL
and	NULL
counted	NULL
after	NULL
incubation	NULL
for	NULL
5	NULL
days	NULL
.	NULL

Cell	NULL
counts	NULL
are	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
determinations	NULL
in	NULL
a	NULL
single	NULL
experiment	NULL
.	NULL

Results	NULL
were	NULL
confirmed	NULL
in	NULL
2	NULL
or	NULL
more	NULL
experiments	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
by	NULL
exponentially	NULL
growing	NULL
,	NULL
unseparated	NULL
cells	NULL
is	NULL
shown	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
for	NULL
3	NULL
or	NULL
more	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
bound	NULL
dexamethasone	NULL
that	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
whole	NULL
cell	NULL
binding	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

108	NULL
f	NULL
&	NULL
R	NULL
4	NULL
A	NULL
Unfractionated	NULL
Unfractionated	NULL
e	NULL
®	NULL
3	NULL
e	NULL
‘	NULL
O	NULL
.	NULL

4	NULL
G	NULL
,	NULL
2	NULL
.	NULL

‘	NULL
.	NULL

$	NULL
Early	NULL
$	NULL
®	NULL
*	NULL
%	NULL
+	NULL
G	NULL
,	NULL
/M	NULL
t-	NULL
*	NULL
og—Aﬂﬂ-ﬁ—	NULL
o	NULL
$	NULL
NUOO—Nub	NULL
¥	NULL
T	NULL
T	NULL
al	NULL
T_T	NULL
*	NULL
%	NULL
0..	NULL
'	NULL
#	NULL
s	NULL
e	NULL
*	NULL
e	NULL
*	NULL
ro	NULL
o	NULL
___	NULL
rm	NULL
m	NULL
___A	NULL
__	NULL
T-	NULL
To	NULL
CT	NULL
-T	NULL
ro	NULL
-_	NULL
LJ	NULL
'	NULL
>	NULL
o	NULL
et	NULL
6	NULL
}	NULL
a	NULL
*	NULL
o	NULL
'	NULL
.	NULL

3	NULL
3	NULL
g	NULL
3	NULL
4+	NULL
4	NULL
al	NULL
®	NULL
O	NULL
2	NULL
)	NULL
jar	NULL
}	NULL
D	NULL
J	NULL
&	NULL
8	NULL
0	NULL
0	NULL
-	NULL
6F-NEE	NULL
a	NULL
4a	NULL
sho	NULL
*	NULL
%	NULL
e	NULL
af-eL	NULL
®	NULL
+	NULL
``	NULL
_	NULL
J	NULL
/\	NULL
n	NULL
o	NULL
a	NULL
?	NULL

*tomase	NULL
o	NULL
i	NULL
6F-4	NULL
be	NULL
3	NULL
5	NULL
5	NULL
3	NULL
®	NULL
e	NULL
4	NULL
}	NULL
-®	NULL
=	NULL
%	NULL
2	NULL
U	NULL
LJ	NULL
2-I	NULL
o	NULL
U	NULL
*	NULL
0	NULL
0	NULL
i	NULL
i	NULL
6F-*	NULL
0	NULL
...	NULL
6	NULL
6	NULL
3	NULL
:	NULL
0	NULL
.	NULL

4~	NULL
2	NULL
o	NULL
0	NULL
.	NULL

2+	NULL
I	NULL
a	NULL
.	NULL

%	NULL
1	NULL
M	NULL
4	NULL
c	NULL
i	NULL
20	NULL
40	NULL
60	NULL
so	NULL
50	NULL
100	NULL
CHANNEL	NULL
NUMBER	NULL
RELATIVE	NULL
FLUORESCENCE	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Cell	NULL
volume	NULL
and	NULL
DNA	NULL
content	NULL
.	NULL

$	NULL
49	NULL
143R	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
6	NULL
fractions	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

Rotor	NULL
speed	NULL
was	NULL
2,000	NULL
rpm	NULL
,	NULL
and	NULL
fraction	NULL
1	NULL
was	NULL
eluted	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
13	NULL
ml/min	NULL
.	NULL

Subsequent	NULL
fractions	NULL
were	NULL
eluted	NULL
at	NULL
15	NULL
,	NULL
17	NULL
,	NULL
19	NULL
,	NULL
21	NULL
,	NULL
and	NULL
25	NULL
ml/min	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
Coulter	NULL
volume	NULL
distribution	NULL
.	NULL

Cell	NULL
volume	NULL
increased	NULL
linearly	NULL
with	NULL
channel	NULL
!	NULL

number	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
DNA	NULL
content	NULL
per	NULL
cell	NULL
histograms	NULL
of	NULL
cells	NULL
stained	NULL
with	NULL
chromomycin	NULL
A	NULL
,	NULL
.	NULL

DNA	NULL
content	NULL
is	NULL
proportional	NULL
to	NULL
fluorescence	NULL
,	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
and	NULL
normalized	NULL
so	NULL
that	NULL
G	NULL
,	NULL
cells	NULL
have	NULL
a	NULL
modal	NULL
fluorescence	NULL
of	NULL
50.	NULL
phase	NULL
estimated	NULL
from	NULL
DNA	NULL
histograms	NULL
was	NULL
higher	NULL
than	NULL
that	NULL
determined	NULL
by	NULL
autoradiography	NULL
.	NULL

These	NULL
differences	NULL
do	NULL
not	NULL
affect	NULL
the	NULL
experimental	NULL
results	NULL
of	NULL
this	NULL
study	NULL
and	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Effect	NULL
of	NULL
Cell	NULL
Cycle	NULL
Position	NULL
on	NULL
Dexamethasone	NULL
Binding	NULL
by	NULL
Mouse	NULL
Lymphoma	NULL
Cells	NULL
Asynchronously	NULL
dividing	NULL
dexamethasone-sensitive	NULL
$	NULL
49	NULL
cells	NULL
(	NULL
W+	NULL
24.32	NULL
clone	NULL
)	NULL
were	NULL
separated	NULL
into	NULL
7	NULL
DISTELHORST	NULL
,	NULL
BENUTTO	NULL
,	NULL
AND	NULL
BERGAMIN	NULL
!	NULL

100	NULL
}	NULL
[	NULL
s	NULL
%	NULL
S	NULL
PHASE	NULL
a	NULL
O	NULL
T	NULL
2	NULL
3	NULL
4	NULL
FRACTION	NULL
NUMBER	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Comparison	NULL
of	NULL
percentage	NULL
S	NULL
phase	NULL
cells	NULL
determined	NULL
by	NULL
autoradiography	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

W7	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
five	NULL
fractions	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

Rotor	NULL
speed	NULL
was	NULL
2,000	NULL
rpm	NULL
,	NULL
and	NULL
fraction	NULL
1	NULL
were	NULL
eluted	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
11	NULL
ml/min	NULL
.	NULL

Subsequent	NULL
fractions	NULL
were	NULL
eluted	NULL
at	NULL
13	NULL
,	NULL
15	NULL
,	NULL
17	NULL
,	NULL
and	NULL
21	NULL
ml/min	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
S	NULL
phase	NULL
cells	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
by	NULL
autoradiography	NULL
{	NULL
closed	NULL
symbols	NULL
)	NULL
and	NULL
by	NULL
computer	NULL
analysis	NULL
of	NULL
flow	NULL
cytometry	NULL
data	NULL
(	NULL
open	NULL
symbols	NULL
)	NULL
.	NULL

Symbols	NULL
are	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
3	NULL
experiments	NULL
.	NULL

fractions	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
specifically	NULL
bound	NULL
per	NULL
cell	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
measured	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Cells	NULL
in	NULL
G	NULL
,	NULL
phase	NULL
(	NULL
fraction	NULL
1	NULL
)	NULL
were	NULL
contaminated	NULL
by	NULL
fewer	NULL
than	NULL
10	NULL
%	NULL
S	NULL
phase	NULL
cells	NULL
and	NULL
bound	NULL
8.84	NULL
+	NULL
0.38	NULL
fmole	NULL
of	NULL
dexametha-	NULL
G	NULL
o	NULL
o	NULL
T	NULL
200f-	NULL
DEXAMETHASONE	NULL
BOUND	NULL
(	NULL
%	NULL
G	NULL
,	NULL
)	NULL
100-is	NULL
L	NULL
t	NULL
<	NULL
&	NULL
sof	NULL
&	NULL
at	NULL
i	NULL
L	NULL
1	NULL
1	NULL
L	NULL
1	NULL
L	NULL
9	NULL
-	NULL
5	NULL
-~3	NULL
4	NULL
--	NULL
§5	NULL
-+	NULL
7	NULL
FRACTION	NULL
NUMBER	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
dexamethasone	NULL
binding	NULL
by	NULL
$	NULL
49	NULL
cells	NULL
.	NULL

$	NULL
49	NULL
W*	NULL
24.32	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
7	NULL
fractions	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

Rotor	NULL
speed	NULL
was	NULL
2,000	NULL
rpm	NULL
,	NULL
and	NULL
fraction	NULL
1	NULL
was	NULL
eluted	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
13	NULL
ml/min	NULL
.	NULL

Subsequent	NULL
fractions	NULL
were	NULL
eluted	NULL
at	NULL
15	NULL
,	NULL
17	NULL
,	NULL
19	NULL
,	NULL
21	NULL
,	NULL
25	NULL
,	NULL
and	NULL
27	NULL
mi/min	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
amount	NULL
bound	NULL
by	NULL
cells	NULL
in	NULL
fraction	NULL
1	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
Percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
measured	NULL
by	NULL
autoradiography	NULL
.	NULL

Symbols	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
7	NULL
experiments	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EFFECT	NULL
OF	NULL
CELL	NULL
CYCLE	NULL
ON	NULL
DEXAMETHASONE	NULL
BINDING	NULL
Table	NULL
2	NULL
.	NULL

Effect	NULL
of	NULL
Cell	NULL
Cycle	NULL
Position	NULL
on	NULL
Binding	NULL
Affinity	NULL
and	NULL
Nuclear	NULL
Translocation	NULL
in	NULL
Dexamethasone-Sensitive	NULL
$	NULL
49	NULL
Cells	NULL
G	NULL
,	NULL
Phase	NULL
S	NULL
Phase	NULL
Dissociation	NULL
constant	NULL
0.40*®	NULL
0.35	NULL
{	NULL
nM	NULL
}	NULL
(	NULL
0.22-0.70	NULL
)	NULL
(	NULL
0.16-0.48	NULL
)	NULL
Dexamethasone	NULL
bound	NULL
{	NULL
fmole/10°	NULL
celts	NULL
)	NULL
Whole	NULL
Call	NULL
4.6	NULL
(	NULL
4.4-4.9	NULL
)	NULL
13.4	NULL
(	NULL
9.2-17.4	NULL
)	NULL
%	NULL
100	NULL
100	NULL
Cytoplasm	NULL
2.3	NULL
(	NULL
1.8-2.8	NULL
)	NULL
4.8	NULL
(	NULL
2.9-6.4	NULL
)	NULL
%	NULL
50	NULL
34	NULL
Nuclei	NULL
2.3	NULL
(	NULL
2.0-2.6	NULL
)	NULL
9.1	NULL
11.0	NULL
)	NULL
%	NULL
50	NULL
66	NULL
$	NULL
49	NULL
W*	NULL
24.32	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
into	NULL
fractions	NULL
corresponding	NULL
to	NULL
G	NULL
,	NULL
phase	NULL
(	NULL
fraction	NULL
1	NULL
)	NULL
and	NULL
S	NULL
phase	NULL
(	NULL
fraction	NULL
5	NULL
)	NULL
{	NULL
refer	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Dissociation	NULL
constants	NULL
were	NULL
calculated	NULL
from	NULL
Scatchard	NULL
plots	NULL
of	NULL
binding	NULL
data	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
binding	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

*Numbers	NULL
are	NULL
the	NULL
mean	NULL
and	NULL
range	NULL
{	NULL
in	NULL
parentheses	NULL
)	NULL
of	NULL
3	NULL
separate	NULL
experiments	NULL
.	NULL

sone	NULL
per	NULL
million	NULL
cells	NULL
(	NULL
mean	NULL
+	NULL
SE	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
increased	NULL
early	NULL
in	NULL
the	NULL
transition	NULL
from	NULL
G	NULL
,	NULL
to	NULL
S	NULL
phase	NULL
(	NULL
fraction	NULL
2	NULL
)	NULL
,	NULL
and	NULL
reached	NULL
a	NULL
maximum	NULL
during	NULL
S	NULL
phase	NULL
(	NULL
fraction	NULL
5	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
between	NULL
fractions	NULL
1	NULL
and	NULL
5	NULL
was	NULL
2.6-fold	NULL
(	NULL
range	NULL
in	NULL
7	NULL
experiments	NULL
,	NULL
2.0-4.2-fold	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
decreased	NULL
in	NULL
fractions	NULL
6	NULL
and	NULL
7	NULL
,	NULL
corresponding	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
during	NULL
the	NULL
S	NULL
to	NULL
G	NULL
,	NULL
/M	NULL
transition	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
receptor	NULL
affinity	NULL
for	NULL
dexamethasone	NULL
was	NULL
essentially	NULL
the	NULL
same	NULL
during	NULL
G	NULL
,	NULL
phase	NULL
(	NULL
fraction	NULL
1	NULL
)	NULL
and	NULL
S	NULL
phase	NULL
(	NULL
fraction	NULL
5	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
specifically	NULL
bound	NULL
dexamethasone	NULL
that	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
increased	NULL
significantly	NULL
between	NULL
G	NULL
,	NULL
phase	NULL
(	NULL
fraction	NULL
1	NULL
)	NULL
and	NULL
S	NULL
phase	NULL
(	NULL
fraction	NULL
5	NULL
)	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
experiments	NULL
in	NULL
which	NULL
another	NULL
dexamethasone-sensitive	NULL
cell	NULL
line	NULL
was	NULL
com	NULL
300F	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
dexamethasone	NULL
binding	NULL
by	NULL
dexamethasone-sensitive	NULL
and	NULL
-resistant	NULL
mouse	NULL
lymphoma	NULL
cells	NULL
.	NULL

W7	NULL
(	NULL
left	NULL
)	NULL
,	NULL
$	NULL
49	NULL
143R	NULL
(	NULL
middle	NULL
}	NULL
,	NULL
and	NULL
$	NULL
49	NULL
22R	NULL
(	NULL
right	NULL
)	NULL
cell	NULL
lines	NULL
were	NULL
sepa-	NULL
T	NULL
100	NULL
DEXAMETHASONE	NULL
BOUND	NULL
(	NULL
%	NULL
G	NULL
,	NULL
)	NULL
ro	NULL
$	NULL
109	NULL
250F-6	NULL
&	NULL
200	NULL
}	NULL
-o	NULL
Z	NULL
3	NULL
O.	NULL
a	NULL
150f	NULL
us	NULL
Z	NULL
O	NULL
9	NULL
©	NULL
100f	NULL
+-L	NULL
b3	NULL
4	NULL
i	NULL
so	NULL
}	NULL
o	NULL
pod	NULL
p	NULL
po	NULL
gpl	NULL
pup	NULL
Ppp	NULL
pl	NULL
p	NULL
p	NULL
g	NULL
I-	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FRACTION	NULL
NUMBER	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
dexamethasone	NULL
binding	NULL
by	NULL
$	NULL
49	NULL
cells	NULL
expressed	NULL
as	NULL
a	NULL
function	NULL
of	NULL
cell	NULL
protein	NULL
.	NULL

The	NULL
same	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
for	NULL
$	NULL
49	NULL
W*	NULL
24.32	NULL
cells	NULL
and	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
for	NULL
$	NULL
49	NULL
143R	NULL
cells	NULL
were	NULL
recalculated	NULL
as	NULL
the	NULL
it	NULL
of	NULL
d	NULL
thasone	NULL
bound	NULL
per	NULL
milligram	NULL
of	NULL
cell	NULL
protein	NULL
.	NULL

Cell	NULL
protein	NULL
increased	NULL
steadily	NULL
with	NULL
each	NULL
fraction	NULL
and	NULL
approximately	NULL
doubled	NULL
between	NULL
the	NULL
first	NULL
and	NULL
last	NULL
fraction	NULL
.	NULL

Dexamethasone	NULL
binding	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
amount	NULL
bound	NULL
in	NULL
fraction	NULL
1	NULL
.	NULL

Symbols	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
multiple	NULL
experiments	NULL
.	NULL

pared	NULL
to	NULL
two	NULL
dexamethasone-resistant	NULL
$	NULL
49	NULL
mutant	NULL
cell	NULL
lines	NULL
in	NULL
terms	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
dexamethasone	NULL
binding	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
phase	NULL
distribution	NULL
of	NULL
separated	NULL
fractions	NULL
was	NULL
similar	NULL
for	NULL
the	NULL
three	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
flow	NULL
cytometry	NULL
data	NULL
.	NULL

The	NULL
G	NULL
,	NULL
phase	NULL
population	NULL
(	NULL
fraction	NULL
1	NULL
)	NULL
of	NULL
each	NULL
cell	NULL
line	NULL
was	NULL
contaminated	NULL
with	NULL
fewer	NULL
than	NULL
10	NULL
%	NULL
S	NULL
phase	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
by	NULL
the	NULL
dexamethasone-sensitive	NULL
W7	NULL
cell	NULL
line	NULL
increased	NULL
progressively	NULL
between	NULL
fractions	NULL
1	NULL
and	NULL
4	NULL
,	NULL
corresponding	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
.	NULL

The	NULL
rated	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
as	NULL
described	NULL
in	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
1	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
(	NULL
top	NULL
)	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
amount	NULL
bound	NULL
by	NULL
cells	NULL
in	NULL
fraction	NULL
1	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
phase	NULL
distribution	NULL
of	NULL
each	NULL
fraction	NULL
(	NULL
bottom	NULL
)	NULL
was	NULL
calculated	NULL
from	NULL
flow	NULL
cytometry	NULL
data	NULL
.	NULL

Symbols	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
3	NULL
experiments	NULL
for	NULL
the	NULL
W7	NULL
clone	NULL
,	NULL
7	NULL
experiments	NULL
for	NULL
the	NULL
$	NULL
49	NULL
143R	NULL
clone	NULL
,	NULL
and	NULL
4	NULL
experiments	NULL
for	NULL
the	NULL
$	NULL
49	NULL
22R	NULL
clone	NULL
.	NULL

CELL	NULL
CYCLE	NULL
PHASE	NULL
(	NULL
%	NULL
)	NULL
é	NULL
A	NULL
%	NULL
A	NULL
P	NULL
t	NULL
%	NULL
A	NULL
2	NULL
J	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FRACTION	NULL
NUMBER	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

110	NULL
mean	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
during	NULL
S	NULL
phase	NULL
was	NULL
2.6-fold	NULL
(	NULL
range	NULL
in	NULL
three	NULL
experiments	NULL
2.3~	NULL
3.2-fold	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
declined	NULL
in	NULL
fraction	NULL
5	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
S	NULL
to	NULL
G	NULL
,	NULL
/M	NULL
transition	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
by	NULL
the	NULL
dexamethasone-resistant	NULL
$	NULL
49	NULL
mutants	NULL
did	NULL
not	NULL
increase	NULL
during	NULL
S	NULL
phase	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
achieved	NULL
when	NULL
dexamethasone	NULL
binding	NULL
was	NULL
expressed	NULL
in	NULL
terms	NULL
of	NULL
cell	NULL
protein	NULL
.	NULL

In	NULL
the	NULL
$	NULL
49	NULL
W*	NULL
24.32	NULL
and	NULL
S49	NULL
143R	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
per	NULL
cell	NULL
increased	NULL
with	NULL
each	NULL
successive	NULL
fraction	NULL
and	NULL
approximately	NULL
doubled	NULL
between	NULL
the	NULL
first	NULL
and	NULL
last	NULL
fraction	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
G	NULL
,	NULL
phase	NULL
population	NULL
of	NULL
$	NULL
49	NULL
W+	NULL
24.32	NULL
and	NULL
$	NULL
49	NULL
143R	NULL
cells	NULL
bound	NULL
226	NULL
+	NULL
10	NULL
and	NULL
168	NULL
+	NULL
13	NULL
fmole	NULL
dexamethasone/mg	NULL
cell	NULL
protein	NULL
,	NULL
respectively	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
by	NULL
$	NULL
49	NULL
W*	NULL
24.32	NULL
cells	NULL
increased	NULL
almost	NULL
twofold	NULL
between	NULL
fractions	NULL
1	NULL
and	NULL
5	NULL
and	NULL
then	NULL
declined	NULL
in	NULL
fractions	NULL
6	NULL
and	NULL
7	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
by	NULL
$	NULL
49	NULL
143R	NULL
cells	NULL
did	NULL
not	NULL
change	NULL
significantly	NULL
between	NULL
fractions	NULL
1	NULL
and	NULL
3	NULL
,	NULL
and	NULL
declined	NULL
between	NULL
fractions	NULL
3	NULL
and	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
Cell	NULL
Cycle	NULL
Position	NULL
on	NULL
Dexamethasone	NULL
Binding	NULL
by	NULL
Human	NULL
Lymphoid	NULL
Cells	NULL
The	NULL
effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
dexamethasone	NULL
binding	NULL
by	NULL
dexamethasone-sensitive	NULL
(	NULL
8226	NULL
)	NULL
and	NULL
-resistant	NULL
(	NULL
IM-9	NULL
)	NULL
human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
was	NULL
compared	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
phase	NULL
distribution	NULL
of	NULL
separated	NULL
fractions	NULL
was	NULL
similar	NULL
for	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
/D	NULL
ro	NULL
ta	NULL
$	NULL
O	NULL
O	NULL
O	NULL
O	NULL
0	NULL
O	NULL
T	NULL
T	NULL
T	NULL
DEXAMETHASONE	NULL
BOUND	NULL
(	NULL
%	NULL
G	NULL
,	NULL
)	NULL
0	NULL
o	NULL
z.	NULL
DISTELHORST	NULL
,	NULL
BENUTTO	NULL
,	NULL
AND	NULL
BERGAMIN	NULL
!	NULL

the	NULL
flow	NULL
cytometry	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

This	NULL
was	NULL
also	NULL
true	NULL
when	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
fraction	NULL
was	NULL
determined	NULL
by	NULL
autoradiography	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
by	NULL
8226	NULL
cells	NULL
increased	NULL
3.4-fold	NULL
between	NULL
fractions	NULL
1	NULL
(	NULL
G	NULL
,	NULL
phase	NULL
)	NULL
and	NULL
4	NULL
(	NULL
S	NULL
phase	NULL
)	NULL
.	NULL

In	NULL
5	NULL
experiments	NULL
,	NULL
the	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
binding	NULL
varied	NULL
from	NULL
2.2	NULL
to	NULL
4.2-fold	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
decreased	NULL
in	NULL
fraction	NULL
5	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
G	NULL
,	NULL
/M	NULL
phase	NULL
transition	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
by	NULL
IM-9	NULL
cells	NULL
did	NULL
not	NULL
change	NULL
significantly	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Control	NULL
Experiments	NULL
In	NULL
order	NULL
to	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
experimental	NULL
results	NULL
were	NULL
an	NULL
artifact	NULL
of	NULL
the	NULL
cell	NULL
separation	NULL
method	NULL
,	NULL
the	NULL
following	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

Two	NULL
G	NULL
,	NULL
phase	NULL
fractions	NULL
of	NULL
8226	NULL
cells	NULL
(	NULL
corresponding	NULL
to	NULL
fractions	NULL
1	NULL
and	NULL
2	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
were	NULL
placed	NULL
in	NULL
culture	NULL
immediately	NULL
after	NULL
they	NULL
were	NULL
collected	NULL
.	NULL

Dexamethasone	NULL
binding	NULL
and	NULL
percentage	NULL
S	NULL
phase	NULL
cells	NULL
were	NULL
measured	NULL
at	NULL
periodic	NULL
time	NULL
intervals	NULL
thereafter	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
increased	NULL
as	NULL
the	NULL
G	NULL
,	NULL
populations	NULL
continued	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
S	NULL
phase	NULL
cells	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
dexamethasone	NULL
binding	NULL
to	NULL
change	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
the	NULL
IM-9	NULL
cell	NULL
line	NULL
was	NULL
confirmed	NULL
by	NULL
experiments	NULL
in	NULL
which	NULL
cells	NULL
were	NULL
synchronized	NULL
by	NULL
double	NULL
thymidine	NULL
blockade	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
dexamethasone	NULL
binding	NULL
by	NULL
human	NULL
lymphoid	NULL
cells	NULL
.	NULL

8226	NULL
{	NULL
left	NULL
)	NULL
and	NULL
IM-9	NULL
(	NULL
right	NULL
)	NULL
cell	NULL
lines	NULL
were	NULL
separated	NULL
into	NULL
5	NULL
and	NULL
6	NULL
fractions	NULL
,	NULL
_9	NULL
Os	NULL
@	NULL
6	NULL
,	NULL
/m	NULL
50	NULL
|	NULL
3	NULL
}	NULL
*	NULL
3	NULL
CELL	NULL
CYCLE	NULL
PHASE	NULL
(	NULL
%	NULL
)	NULL
FRACTION	NULL
NUMBER	NULL
respectively	NULL
,	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

Rotor	NULL
speed	NULL
was	NULL
1,600	NULL
rpm	NULL
,	NULL
and	NULL
the	NULL
flow	NULL
rate	NULL
that	NULL
eluted	NULL
the	NULL
first	NULL
fraction	NULL
was	NULL
9	NULL
and	NULL
7	NULL
ml/min	NULL
for	NULL
8226	NULL
and	NULL
IM-9	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Subsequent	NULL
fractions	NULL
were	NULL
eluted	NULL
by	NULL
increasing	NULL
the	NULL
flow	NULL
rate	NULL
by	NULL
2	NULL
ml/min	NULL
increments	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
(	NULL
top	NULL
)	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
amount	NULL
bound	NULL
by	NULL
cells	NULL
in	NULL
fraction	NULL
1	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
phase	NULL
distribution	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
fraction	NULL
(	NULL
bottom	NULL
)	NULL
was	NULL
calculated	NULL
from	NULL
flow	NULL
cytometry	NULL
data	NULL
.	NULL

Symbols	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
3	NULL
experiments	NULL
for	NULL
8226	NULL
and	NULL
4	NULL
experiments	NULL
for	NULL
IM-9	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EFFECT	NULL
OF	NULL
CELL	NULL
CYCLE	NULL
ON	NULL
DEXAMETHASONE	NULL
BINDING	NULL
o	NULL
o	NULL
O	NULL
_	NULL
a	NULL
a	NULL
iw	NULL
©	NULL
2	NULL
7°	NULL
10	NULL
}	NULL
-2	NULL
o	NULL
6	NULL
<	NULL
o	NULL
&	NULL
£	NULL
s*	NULL
5	NULL
}	NULL
<	NULL
x	NULL
ta	NULL
)	NULL
o	NULL
0	NULL
©	NULL
uw	NULL
[	NULL
¢\¢	NULL
2	NULL
so	NULL
}	NULL
T	NULL
a.	NULL
a	NULL
0	NULL
a	NULL
|	NULL
M	NULL
1	NULL
J_	NULL
12	NULL
24	NULL
TIME	NULL
(	NULL
hours	NULL
)	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

-	NULL
Change	NULL
in	NULL
dexamethasone	NULL
binding	NULL
after	NULL
G	NULL
,	NULL
to	NULL
S	NULL
phase	NULL
transition	NULL
.	NULL

8226	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
2	NULL
fractions	NULL
,	NULL
which	NULL
correspond	NULL
to	NULL
fractions	NULL
1	NULL
and	NULL
2	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
(	NULL
top	NULL
)	NULL
was	NULL
measured	NULL
immediately	NULL
after	NULL
the	NULL
fractions	NULL
were	NULL
collected	NULL
(	NULL
0	NULL
hr	NULL
)	NULL
and	NULL
at	NULL
18	NULL
hr	NULL
and	NULL
24	NULL
hr	NULL
of	NULL
incubation	NULL
.	NULL

The	NULL
percent	NULL
S	NULL
phase	NULL
cells	NULL
(	NULL
bottom	NULL
}	NULL
at	NULL
each	NULL
time	NULL
point	NULL
was	NULL
measured	NULL
by	NULL
autoradiography	NULL
.	NULL

Symbols	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
triplicate	NULL
determinations	NULL
in	NULL
2	NULL
separate	NULL
experiments	NULL
.	NULL

Closed	NULL
symbols	NULL
,	NULL
fraction	NULL
1	NULL
.	NULL

Open	NULL
symbols	NULL
,	NULL
fraction	NULL
2	NULL
.	NULL

DISCUSSION	NULL
The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
dexamethasone	NULL
binding	NULL
by	NULL
dexamethasone-sensitive	NULL
lymphoid	NULL
cell	NULL
lines	NULL
increases	NULL
2-4-fold	NULL
during	NULL
the	NULL
S	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
was	NULL
not	NULL
accompanied	NULL
by	NULL
a	NULL
change	NULL
in	NULL
the	NULL
affinity	NULL
of	NULL
receptors	NULL
for	NULL
dexamethasone	NULL
but	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
small	NULL
but	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
dexamethasone-receptor	NULL
complexes	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

Dexamethasone	NULL
binding	NULL
appeared	NULL
to	NULL
increase	NULL
early	NULL
in	NULL
S	NULL
phase	NULL
and	NULL
to	NULL
decline	NULL
in	NULL
late	NULL
S	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
phases	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
dexamethasone-sensitive	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
by	NULL
three	NULL
dexamethasone-resistant	NULL
cell	NULL
lines	NULL
did	NULL
not	NULL
change	NULL
significantly	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
correlation	NULL
between	NULL
sensitivity	NULL
to	NULL
growth	NULL
inhibition	NULL
by	NULL
dexamethasone	NULL
and	NULL
an	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
suggests	NULL
that	NULL
an	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
might	NULL
be	NULL
necessary	NULL
in	NULL
order	NULL
for	NULL
dexamethasone	NULL
to	NULL
inhibit	NULL
cell	NULL
growth	NULL
.	NULL

That	NULL
a	NULL
change	NULL
in	NULL
dexamethasone	NULL
binding	NULL
of	NULL
the	NULL
magnitude	NULL
observed	NULL
here	NULL
might	NULL
be	NULL
functionally	NULL
important	NULL
is	NULL
supported	NULL
by	NULL
previous	NULL
work	NULL
by	NULL
other	NULL
investigators	NULL
.	NULL

First	NULL
,	NULL
studies	NULL
of	NULL
$	NULL
49	NULL
mouse	NULL
lymphoma	NULL
cell	NULL
hybrids	NULL
showed	NULL
that	NULL
a	NULL
111	NULL
twofold	NULL
reduction	NULL
in	NULL
dexamethasone	NULL
binding	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
twofold	NULL
reduction	NULL
in	NULL
cell	NULL
killing	NULL
by	NULL
dexamethasone	NULL
.	NULL
``	NULL

Second	NULL
,	NULL
derivatives	NULL
of	NULL
the	NULL
W7	NULL
mouse	NULL
thymoma	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
have	NULL
about	NULL
half	NULL
of	NULL
the	NULL
receptor	NULL
content	NULL
of	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
,	NULL
are	NULL
more	NULL
resistant	NULL
than	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
to	NULL
dexamethasone	NULL
.	NULL
``	NULL

The	NULL
reason	NULL
why	NULL
an	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
during	NULL
S	NULL
phase	NULL
should	NULL
be	NULL
needed	NULL
in	NULL
order	NULL
for	NULL
dexamethasone	NULL
to	NULL
inhibit	NULL
cell	NULL
growth	NULL
is	NULL
not	NULL
understood	NULL
at	NULL
the	NULL
present	NULL
time	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
results	NULL
of	NULL
this	NULL
study	NULL
suggest	NULL
that	NULL
an	NULL
absence	NULL
of	NULL
the	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
could	NULL
represent	NULL
a	NULL
new	NULL
mechanism	NULL
of	NULL
dexamethasone	NULL
resistance	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
.	NULL

dexamethasone	NULL
binding	NULL
during	NULL
S	NULL
phase	NULL
is	NULL
not	NULL
directly	NULL
required	NULL
for	NULL
mediating	NULL
growth	NULL
inhibition	NULL
by	NULL
dexamethasone	NULL
but	NULL
is	NULL
secondary	NULL
to	NULL
another	NULL
cell-cycle-related	NULL
process	NULL
that	NULL
is	NULL
required	NULL
in	NULL
order	NULL
for	NULL
dexamethasone	NULL
to	NULL
inhibit	NULL
cell	NULL
growth	NULL
.	NULL

The	NULL
most	NULL
simple	NULL
explanation	NULL
for	NULL
changes	NULL
in	NULL
dexamethasone	NULL
binding	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
is	NULL
that	NULL
the	NULL
number	NULL
of	NULL
dexamethasone	NULL
receptors	NULL
per	NULL
cell	NULL
increases	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
increase	NULL
in	NULL
cell	NULL
size	NULL
``	NULL
``	NULL
and	NULL
cellular	NULL
protein	NULL
content	NULL
,	NULL
``	NULL
which	NULL
occurs	NULL
as	NULL
cells	NULL
progress	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
preparation	NULL
for	NULL
mitosis	NULL
.	NULL

Thus	NULL
,	NULL
one	NULL
might	NULL
expect	NULL
that	NULL
the	NULL
number	NULL
of	NULL
dexamethasone	NULL
receptors	NULL
per	NULL
cell	NULL
should	NULL
approximately	NULL
double	NULL
between	NULL
G	NULL
,	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
phases	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
indicate	NULL
that	NULL
this	NULL
explanation	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
correct	NULL
.	NULL

First	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
increased	NULL
maximally	NULL
during	NULL
S	NULL
phase	NULL
and	NULL
decreased	NULL
during	NULL
late	NULL
S	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
phase	NULL
,	NULL
even	NULL
though	NULL
cell	NULL
size	NULL
continued	NULL
to	NULL
increase	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
milligram	NULL
of	NULL
cell	NULL
protein	NULL
increased	NULL
during	NULL
S	NULL
phase	NULL
and	NULL
decreased	NULL
during	NULL
G	NULL
,	NULL
/M	NULL
phase	NULL
.	NULL

Third	NULL
,	NULL
as	NULL
pointed	NULL
out	NULL
before	NULL
,	NULL
there	NULL
was	NULL
no	NULL
change	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
dexamethasone	NULL
bound	NULL
per	NULL
cell	NULL
in	NULL
the	NULL
case	NULL
of	NULL
three	NULL
dexamethasone-resistant	NULL
cell	NULL
lines	NULL
,	NULL
even	NULL
though	NULL
cell	NULL
size	NULL
and	NULL
protein	NULL
content	NULL
increased	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Therefore	NULL
,	NULL
another	NULL
mechanism	NULL
must	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
cell-cycle-related	NULL
change	NULL
in	NULL
dexamethasone	NULL
binding	NULL
.	NULL

One	NULL
potential	NULL
mechanism	NULL
is	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
receptor	NULL
synthesis	NULL
during	NULL
S	NULL
phase	NULL
,	NULL
although	NULL
most	NULL
cell	NULL
proteins	NULL
are	NULL
synthesized	NULL
at	NULL
a	NULL
constant	NULL
rate	NULL
throughout	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL
``	NULL

Inhibitors	NULL
of	NULL
RNA	NULL
and	NULL
protein	NULL
synthesis	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
the	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
by	NULL
HeLa	NULL
Cells	NULL
.	NULL
``	NULL

Another	NULL
potential	NULL
explanation	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
during	NULL
S	NULL
phase	NULL
is	NULL
the	NULL
activation	NULL
of	NULL
existing	NULL
receptors	NULL
from	NULL
a	NULL
non-steroid-binding	NULL
form	NULL
,	NULL
or	NULL
proreceptor	NULL
,	NULL
to	NULL
a	NULL
form	NULL
that	NULL
binds	NULL
steroid	NULL
.	NULL

This	NULL
hypothesis	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
demonstrating	NULL
that	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
lymphoid	NULL
cells	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

112	NULL
can	NULL
be	NULL
rapidly	NULL
inactivated	NULL
and	NULL
reactivated	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
receptor	NULL
dephosphorylation	NULL
and	NULL
phosphoryla-tion.20.29	NULL
The	NULL
mechanism	NULL
responsible	NULL
for	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
in	NULL
dexamethasone-resistant	NULL
cell	NULL
lines	NULL
is	NULL
unknown	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
absence	NULL
of	NULL
an	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
was	NULL
observed	NULL
in	NULL
receptor-defective	NULL
variants	NULL
of	NULL
the	NULL
$	NULL
49	NULL
mouse	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
have	NULL
nuclear	NULL
transfer	NULL
increased	NULL
(	NULL
S49	NULL
143R	NULL
)	NULL
and	NULL
nuclear	NULL
transfer	NULL
deficient	NULL
(	NULL
S49	NULL
22R	NULL
)	NULL
phenotypes	NULL
.	NULL

Therefore	NULL
,	NULL
absence	NULL
of	NULL
an	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
limited	NULL
to	NULL
cells	NULL
that	NULL
have	NULL
a	NULL
particular	NULL
type	NULL
of	NULL
receptor	NULL
defect	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
studies	NULL
of	NULL
the	NULL
IM-9	NULL
cell	NULL
line	NULL
indicate	NULL
that	NULL
absence	NULL
of	NULL
an	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
can	NULL
occur	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
that	NULL
has	NULL
normally	NULL
functioning	NULL
dexamethasone	NULL
receptors	NULL
.	NULL

Although	NULL
the	NULL
proliferation	NULL
of	NULL
IM-9	NULL
cells	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
dexamethasone	NULL
,	NULL
dexametha-	NULL
DISTELHORST	NULL
,	NULL
BENUTTO	NULL
,	NULL
AND	NULL
BERGAMIN	NULL
!	NULL

sone	NULL
induces	NULL
an	NULL
increase	NULL
in	NULL
insulin	NULL
receptor	NULL
synthesis	NULL
in	NULL
IM-9	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
process	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
dexamethasone	NULL
receptors	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
studies	NULL
with	NULL
the	NULL
IM-9	NULL
cell	NULL
line	NULL
suggest	NULL
that	NULL
absence	NULL
of	NULL
an	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
may	NULL
not	NULL
be	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
dexamethasone	NULL
receptors	NULL
themselves	NULL
,	NULL
but	NULL
may	NULL
be	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
a	NULL
nonreceptor	NULL
function	NULL
or	NULL
factor	NULL
that	NULL
regulates	NULL
dexamethasone	NULL
binding	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
,	NULL
through	NULL
a	NULL
loss	NULL
of	NULL
the	NULL
S	NULL
phase	NULL
increase	NULL
in	NULL
glucocorticoid	NULL
binding	NULL
during	NULL
development	NULL
,	NULL
lymphoid	NULL
cells	NULL
could	NULL
become	NULL
resistant	NULL
to	NULL
the	NULL
growth	NULL
inhibitory	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
while	NULL
maintaining	NULL
otherwise	NULL
normal	NULL
receptor	NULL
function	NULL
and	NULL
sensitivity	NULL
to	NULL
other	NULL
actions	NULL
of	NULL
glucocorti-coids	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Steven	NULL
Micko	NULL
for	NULL
his	NULL
assistance	NULL
in	NULL
the	NULL
performance	NULL
of	NULL
flow	NULL
cytometry	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Munck	NULL
A	NULL
:	NULL
General	NULL
aspects	NULL
of	NULL
steroid	NULL
hormone-receptor	NULL
inter-actions	NULL
,	NULL
in	NULL
:	NULL
Pasqualini	NULL
JR	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Receptors	NULL
and	NULL
Mechanisms	NULL
of	NULL
Action	NULL
of	NULL
Steroid	NULL
Hormones-Part	NULL
I	NULL
.	NULL

New	NULL
York	NULL
,	NULL
Marcel	NULL
Dekker	NULL
,	NULL
1976	NULL
,	NULL
pp	NULL
1-39	NULL
2	NULL
.	NULL

Steinberg	NULL
RA	NULL
,	NULL
Levinson	NULL
BB	NULL
,	NULL
Tompkins	NULL
GM	NULL
:	NULL
Kinetics	NULL
of	NULL
steroid	NULL
induction	NULL
and	NULL
deinduction	NULL
of	NULL
tyrosine	NULL
aminotransferase	NULL
synthesis	NULL
in	NULL
cultured	NULL
hepatoma	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
72:2007	NULL
,	NULL
1975	NULL
3	NULL
.	NULL

Claman	NULL
HN	NULL
:	NULL
Corticosteroids	NULL
and	NULL
lymphoid	NULL
cells	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
287:388	NULL
,	NULL
1972	NULL
4	NULL
.	NULL

Yamamoto	NULL
KR	NULL
,	NULL
Gehring	NULL
U	NULL
,	NULL
Stampfer	NULL
MR	NULL
,	NULL
Sibley	NULL
CH	NULL
:	NULL
Genetic	NULL
approaches	NULL
to	NULL
steroid	NULL
hormone	NULL
action	NULL
.	NULL

Rec	NULL
Prog	NULL
Hormone	NULL
Res	NULL
32:3	NULL
,	NULL
1976	NULL
5	NULL
.	NULL

Carlstedt-Duke	NULL
J	NULL
,	NULL
Okret	NULL
S	NULL
,	NULL
Wrange	NULL
O	NULL
,	NULL
Gustafsson	NULL
J	NULL
:	NULL
Immunochemical	NULL
analysis	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
third	NULL
domain	NULL
separate	NULL
from	NULL
the	NULL
steroid-binding	NULL
and	NULL
DNA-binding	NULL
domains	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
79:4260	NULL
,	NULL
1982	NULL
6	NULL
.	NULL

Stevens	NULL
J	NULL
,	NULL
Eisen	NULL
HJ	NULL
,	NULL
Stevens	NULL
YW	NULL
,	NULL
Haubenstock	NULL
H	NULL
,	NULL
Rosenthal	NULL
,	NULL
RL	NULL
,	NULL
Artishevsky	NULL
A	NULL
:	NULL
Immunochemical	NULL
differences	NULL
between	NULL
glucocorticoid	NULL
receptors	NULL
from	NULL
corticoid	NULL
sensitive	NULL
and	NULL
resistant	NULL
malignant	NULL
lymphocytes	NULL
.	NULL

Cancer	NULL
Res	NULL
41:1	NULL
34	NULL
,	NULL
1981	NULL
7	NULL
.	NULL

Cidlowski	NULL
JA	NULL
,	NULL
Michaels	NULL
GA	NULL
:	NULL
Alterations	NULL
in	NULL
glucocorticoid	NULL
binding	NULL
site	NULL
number	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Nature	NULL
266:643	NULL
,	NULL
1977	NULL
8	NULL
.	NULL

Neifeld	NULL
JP	NULL
,	NULL
Lippman	NULL
ME	NULL
,	NULL
Tormey	NULL
DC	NULL
:	NULL
Steroid	NULL
hormone	NULL
receptors	NULL
in	NULL
normal	NULL
human	NULL
lymphocytes	NULL
.	NULL

Induction	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
activity	NULL
by	NULL
phytohemagglutinin	NULL
stimulation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
252:2972	NULL
,	NULL
1977	NULL
9	NULL
.	NULL

Smith	NULL
KA	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Kennedy	NULL
SJ	NULL
,	NULL
Munck	NULL
AU	NULL
:	NULL
Glucocorticoid	NULL
receptors	NULL
and	NULL
glucocorticoid	NULL
sensitivity	NULL
of	NULL
mitogen	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
human	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
267:523	NULL
,	NULL
1977	NULL
10	NULL
.	NULL

Crabtree	NULL
GR	NULL
,	NULL
Munck	NULL
A	NULL
,	NULL
Smith	NULL
KA	NULL
:	NULL
Glucocorticoids	NULL
and	NULL
lymphocytes	NULL
:	NULL
II	NULL
.	NULL

Cell	NULL
cycle-dependent	NULL
changes	NULL
in	NULL
glucocorticoid	NULL
receptor	NULL
content	NULL
.	NULL

J	NULL
Immunol	NULL
125:13	NULL
,	NULL
1980	NULL
11	NULL
.	NULL

Kaiser	NULL
N	NULL
,	NULL
Bourne	NULL
HR	NULL
,	NULL
Insel	NULL
PA	NULL
,	NULL
Coffino	NULL
P	NULL
:	NULL
Regulation	NULL
of	NULL
phosphodiesterase	NULL
and	NULL
ornithine	NULL
decarboxylase	NULL
by	NULL
cAMP	NULL
is	NULL
cell	NULL
cycle	NULL
dependent	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
101:369	NULL
,	NULL
1979	NULL
12	NULL
.	NULL

Distelhorst	NULL
CW	NULL
,	NULL
Benutto	NULL
BM	NULL
,	NULL
Bergamini	NULL
RA	NULL
:	NULL
Centrifugal	NULL
elutriation	NULL
of	NULL
human	NULL
lymphoid	NULL
cells	NULL
:	NULL
Synchronization	NULL
and	NULL
separation	NULL
of	NULL
aneuploid	NULL
cells	NULL
into	NULL
diploid	NULL
and	NULL
tetraploid	NULL
populations	NULL
.	NULL

Cell	NULL
Immunol	NULL
79:68	NULL
,	NULL
1983	NULL
13	NULL
.	NULL

Gray	NULL
JW	NULL
,	NULL
Coffino	NULL
P	NULL
:	NULL
Cell	NULL
cycle	NULL
analysis	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Meth	NULL
Enzymol	NULL
58:233	NULL
,	NULL
1979	NULL
14	NULL
.	NULL

Dean	NULL
PN	NULL
,	NULL
Jett	NULL
JJ	NULL
:	NULL
Mathematical	NULL
analysis	NULL
of	NULL
DNA	NULL
distributions	NULL
derived	NULL
from	NULL
flow	NULL
microfluorometry	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
60:523	NULL
,	NULL
1974	NULL
15	NULL
.	NULL

Distelhorst	NULL
CW	NULL
,	NULL
Cramer	NULL
K	NULL
,	NULL
Rogers	NULL
JC	NULL
:	NULL
Selective	NULL
release	NULL
of	NULL
excreted	NULL
DNA	NULL
sequences	NULL
from	NULL
phytohemagglutinin-stimulated	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
:	NULL
Effects	NULL
of	NULL
trypsin	NULL
and	NULL
divalent	NULL
cations	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
16:1204	NULL
,	NULL
1978	NULL
16	NULL
.	NULL

Stein	NULL
GH	NULL
,	NULL
Yanishevsky	NULL
R	NULL
:	NULL
Autoradiography	NULL
.	NULL

Meth	NULL
Enzymol	NULL
58:279	NULL
,	NULL
1979	NULL
17	NULL
.	NULL

Distelhorst	NULL
CW	NULL
,	NULL
Benutto	NULL
BM	NULL
:	NULL
Glucocorticoid	NULL
receptor	NULL
content	NULL
of	NULL
T	NULL
lymphocytes	NULL
:	NULL
Evidence	NULL
for	NULL
heterogeneity	NULL
.	NULL

J	NULL
Immunol	NULL
126:1630	NULL
,	NULL
1981	NULL
18	NULL
.	NULL

Berger	NULL
SL	NULL
,	NULL
Cooper	NULL
HL	NULL
:	NULL
Very	NULL
short-lived	NULL
and	NULL
stable	NULL
mRNA	NULL
's	NULL
from	NULL
resting	NULL
human	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
72:3873	NULL
,	NULL
1975	NULL
19	NULL
.	NULL

Bradford	NULL
M	NULL
:	NULL
A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantita-tion	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein	NULL
dye	NULL
binding	NULL
.	NULL

Anal	NULL
Biochem	NULL
72:248	NULL
,	NULL
1976	NULL
20	NULL
.	NULL

Wheeler	NULL
RH	NULL
,	NULL
Leach	NULL
KL	NULL
,	NULL
LaForest	NULL
AC	NULL
,	NULL
O'Toole	NULL
TE	NULL
,	NULL
Wagner	NULL
R	NULL
,	NULL
Pratt	NULL
NB	NULL
:	NULL
Glucocorticoid	NULL
receptor	NULL
activation	NULL
and	NULL
inactivation	NULL
in	NULL
cultured	NULL
human	NULL
lymphocytes	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
256:434	NULL
,	NULL
1981	NULL
21	NULL
.	NULL

Baisch	NULL
H	NULL
,	NULL
Beck	NULL
HP	NULL
,	NULL
Christensen	NULL
IJ	NULL
,	NULL
Hartmann	NULL
NR	NULL
,	NULL
Fried	NULL
J	NULL
,	NULL
Dean	NULL
PN	NULL
,	NULL
Gray	NULL
JW	NULL
,	NULL
Jett	NULL
JH	NULL
,	NULL
Johnston	NULL
DA	NULL
,	NULL
White	NULL
RA	NULL
,	NULL
Nicolini	NULL
C	NULL
,	NULL
Zeitz	NULL
S	NULL
,	NULL
Watson	NULL
JV	NULL
:	NULL
A	NULL
comparison	NULL
of	NULL
mathematical	NULL
methods	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
DNA	NULL
histograms	NULL
obtained	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Cell	NULL
Tissue	NULL
Kinet	NULL
15:235	NULL
,	NULL
1982	NULL
22	NULL
.	NULL

Bourgeois	NULL
S	NULL
,	NULL
Newby	NULL
RF	NULL
:	NULL
Diploid	NULL
and	NULL
haploid	NULL
states	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
gene	NULL
of	NULL
mouse	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Cell	NULL
11:423	NULL
,	NULL
1977	NULL
23	NULL
.	NULL

Terasima	NULL
T	NULL
,	NULL
Tolmach	NULL
LJ	NULL
:	NULL
Growth	NULL
and	NULL
nucleic	NULL
acid	NULL
synthesis	NULL
in	NULL
synchronously	NULL
dividing	NULL
populations	NULL
of	NULL
HeLa	NULL
cells	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
30:344	NULL
,	NULL
1963	NULL
24	NULL
.	NULL

Anderson	NULL
EC	NULL
,	NULL
Bell	NULL
GI	NULL
,	NULL
Peterson	NULL
DF	NULL
,	NULL
Tobey	NULL
RA	NULL
:	NULL
Cell	NULL
growth	NULL
and	NULL
division	NULL
:	NULL
IV	NULL
.	NULL

Determination	NULL
of	NULL
volume	NULL
growth	NULL
rate	NULL
and	NULL
division	NULL
probability	NULL
.	NULL

Biophys	NULL
J	NULL
9:246	NULL
,	NULL
1969	NULL
25	NULL
.	NULL

Zetterberg	NULL
A	NULL
,	NULL
Killander	NULL
D	NULL
:	NULL
Quantitative	NULL
cytophotometric	NULL
and	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EFFECT	NULL
OF	NULL
CELL	NULL
CYCLE	NULL
ON	NULL
DEXAMETHASONE	NULL
BINDING	NULL
autoradiographic	NULL
studies	NULL
on	NULL
the	NULL
rate	NULL
of	NULL
protein	NULL
synthesis	NULL
in	NULL
mouse	NULL
fibroblasts	NULL
in	NULL
vitro	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
40:1	NULL
,	NULL
1965	NULL
26	NULL
.	NULL

Milcarek	NULL
C	NULL
,	NULL
Zahn	NULL
K	NULL
;	NULL
The	NULL
synthesis	NULL
of	NULL
ninety	NULL
proteins	NULL
including	NULL
actin	NULL
throughout	NULL
the	NULL
HeLa	NULL
cell	NULL
cycle	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
79:833	NULL
,	NULL
1978	NULL
27	NULL
.	NULL

Bravo	NULL
R	NULL
,	NULL
Celis	NULL
JE	NULL
:	NULL
A	NULL
search	NULL
for	NULL
differential	NULL
polypeptide	NULL
synthesis	NULL
throughout	NULL
the	NULL
cell	NULL
cycle	NULL
of	NULL
HeLa	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
84:795	NULL
,	NULL
1980	NULL
28	NULL
.	NULL

Cidlowski	NULL
JA	NULL
,	NULL
Cidlowski	NULL
NB	NULL
:	NULL
Glucocorticoid	NULL
receptors	NULL
and	NULL
the	NULL
cell	NULL
cycle	NULL
:	NULL
Evidence	NULL
that	NULL
the	NULL
accumulation	NULL
of	NULL
glucocorticoid	NULL
113	NULL
receptors	NULL
during	NULL
the	NULL
S	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
is	NULL
dependent	NULL
on	NULL
ribonucleic	NULL
acid	NULL
and	NULL
protein	NULL
synthesis	NULL
.	NULL

Endocrinology	NULL
110:1653	NULL
,	NULL
1982	NULL
29	NULL
.	NULL

Munck	NULL
A	NULL
,	NULL
Brinck-Johnson	NULL
T	NULL
:	NULL
Specific	NULL
and	NULL
nonspecific	NULL
phys-iochemical	NULL
interactions	NULL
of	NULL
glucocorticoids	NULL
and	NULL
related	NULL
steroids	NULL
with	NULL
rat	NULL
thymus	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
243	NULL
:	NULL
5556	NULL
,	NULL
1968	NULL
30	NULL
.	NULL

Fantus	NULL
IG	NULL
,	NULL
Saviolakis	NULL
GA	NULL
,	NULL
Hedo	NULL
JA	NULL
,	NULL
Gorden	NULL
P	NULL
:	NULL
Mechanism	NULL
of	NULL
glucoceorticoid-induced	NULL
increase	NULL
in	NULL
insulin	NULL
receptors	NULL
of	NULL
cultured	NULL
human	NULL
lymphocytes	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
257:8277	NULL
,	NULL
1982	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

b100d®	NULL
1984	NULL
63	NULL
:	NULL
105-113	NULL
Effect	NULL
of	NULL
cell	NULL
cycle	NULL
position	NULL
on	NULL
dexamethasone	NULL
binding	NULL
by	NULL
mouse	NULL
and	NULL
human	NULL
lymphoid	NULL
cell	NULL
lines	NULL
:	NULL
correlation	NULL
between	NULL
an	NULL
increase	NULL
in	NULL
dexamethasone	NULL
binding	NULL
during	NULL
S	NULL
phase	NULL
and	NULL
dexamethasone	NULL
sensitivity	NULL
CW	NULL
Distelhorst	NULL
,	NULL
BM	NULL
Benutto	NULL
and	NULL
RA	NULL
Bergamini	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
¢	NULL
“	NULL
f.9	NULL
'	NULL
.	NULL
'	NULL

e	NULL
>	NULL
\	NULL
/	NULL
{	NULL
®	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/63/1/105.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

